New Delhi: Several studies on Covaxin have demonstrated an excellent safety track record, said Bharat Biotech on Thursday, after a study raised concerns of stroke and Guillain-Barre syndrome (rare autoimmune disorder that affects the nerves) a year after taking the Covid-19 vaccine. The study, led by Banaras Hindu University (BHU), claimed that Covaxin raised the rare risk of stroke, and Guillain-Barre syndrome, among others.
Vidya is an accomplished news writer known for her expertise in transforming complex news stories into engaging infographics. With a sharp eye for detail and a talent for visual storytelling, Vidya makes intricate news captivating for our audience.
+ There are no comments
Add yours